Type:
Educational Exhibit
Keywords:
Cancer, Diagnostic procedure, Ultrasound, MR, CT, Oncology
Authors:
C. Botía González1, L. Martinez Encarnacion1, M. L. Masó Navarro2, I. Vicente Zapata1, M. J. GAYÁN BELMONTE1, I. CASES SUSARTE1, M. Lozano Ros1, J. Trejo Falcón1, B. Márquez Argente del Castillo1; 1Murcia/ES, 2Cartagena/ES
DOI:
10.26044/ecr2019/C-2559
Background
Lung cancer remains the main cause of cancer-related death worldwide.
Accurate staging of the M descriptor of this neoplasm,
which is present in about 60% of the patients,
is of paramount importance and has a big impact on its management.
In the current 8th TNM edition of lung cancer,
a distinction is made between regional metastatic disease (M1a),
solitary distant (M1b),
and multiple distant (M1c) metastatic disease,
because of differences in the survival of the patients.
For the staging of this neoplasm,
apart from the thoracic and upper abdominal contrast enhanced CT scan,
other imaging techniques are also useful,
as for example,
PET/CT imaging,
which helps detect occult metastatic disease (with common sites including the adrenal glands,
liver,
and skeleton).
This is important because detection of metastatic disease usually spares the patient from radical treatment.